Pharmacokinetics of a Single Dose of Ceftaroline Fosamil in Children Ages Birth to Younger Than 12 Years With Suspected or Confirmed Systemic Infection.

Trial Profile

Pharmacokinetics of a Single Dose of Ceftaroline Fosamil in Children Ages Birth to Younger Than 12 Years With Suspected or Confirmed Systemic Infection.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Sep 2015

At a glance

  • Drugs Ceftaroline fosamil (Primary)
  • Indications Bacterial infections
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Cerexa; Forest Laboratories
  • Most Recent Events

    • 21 Sep 2015 Pooled analysis results from this trial and other 4 trials presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy.
    • 01 Feb 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 01 May 2012 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top